The Middle-East & Africa Nanotechnology in Medical Device Market which is a USD 678 Million industry in the year 2018 is expected to reach USD 1317 Million by 2023 with a growth rate of 14.2%. The significant growth of the market since last decade is attributed to the technology evolution, increasing aging population and incidences of diseases. The nanotechnology in medicine is trusted to have a greater impact in the treatment, diagnosis and prevention of diseases.
Nanotechnology based medical devices involves dimensions that are tiny fractions of the width of a human hair and is set to revolutionise the healthcare sector. With many nanotechnology applications in the pipeline, it offers many exciting opportunities and is believed to detect and treat the human body damages in the future.
The market is driven by a list of factors that include rising investments in research and development of nanotechnology with international collaboration, rising aging population, increasing awareness, growing expenditure with increased availability of insurance coverage and reimbursement. However, there are few factors hampering the growth of the market that include high cost involving nanotechnology devices and stringent regulatory policies.
The Middle-East & Africa nanotechnology in medical devices market on the basis of product type is segmented into implantable material, biochips, medical textile and wound dressing, active implantable material and others. The implantable material is sub-segmented into bone restorative material and dental filling material. The active implantable material is sub-segmented as hearing aid devices, cardio rhythm management devices and rental implants. Based on the application the market is categorised as diagnostics, therapeutics and research applications. On the basis of geographical region, the nanotechnology based medical device market is divided as UAE, Saudi Arabia Israel and South Africa.
The market is dominated by the companies like AMAG pharmaceuticals, Jude Medical, Inc., Smith & Nephew, Inc., PerkinElmer, Inc., Acusphere, Inc., 3M Company, Affymetrix, Inc., Starkey Hearing Technologies and Stryker Corporation.
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3.1 Executive Summary
3.2 Key Inferences
3.3 New Developments
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5.1 By Product
5.1.1 Implantable Material
5.1.1.1 Bone Restorative Material
5.1.1.2 Dental Filling Material
5.1.2active implantable material
5.1.2.1 Hearing Aid Devices
5.1.2.2 Cardio Rhythm Management Devices
5.1.3 Biochips
5.1.4 Medical Textile and Wound Dressing
5.1.5 Others
5.2 By Application
5.2.1 Diagnostics
5.2.2 Therapeutics
5.2.3 Research
6.1 Introduction
6.2 Middle-East
6.3 Africa
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8.1 Acusphere, Inc.
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Strategic Evaluation and Operations
8.1.4 Financial analysis
8.1.5 Legal issues
8.1.6 Recent Developments
8.1.7 SWOT analysis
8.1.8 Analyst View
8.2 AMAG Pharmaceuticals
8.3 Stryker Corporation
8.4 3M Company
8.5 St. Jude Medical, Inc.
8.6 Affymetrix, Inc.
8.7 Smith & Nephew, Inc.
8.8 PerkinElmer, Inc.
8.9 Starkey Hearing Technologies
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10.1 Market Outlook
10.2 Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
